Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Lymphoma 155Leukemia 127Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Lymphoma, Non-Hodgkin 81Leukemia, Myeloid, Acute 80Lymphoma, Large B-Cell, Diffuse 75Multiple Myeloma 71Lymphoma, Follicular 64Hodgkin Disease 64Breast Neoplasms 64Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Mantle-Cell 62Burkitt Lymphoma 60Myelodysplastic Syndromes 55Lymphoma, Large-Cell, Immunoblastic 53Sarcoma 41Lymphoma, B-Cell, Marginal Zone 40Neuroblastoma 37Central Nervous System Neoplasms 34Neoplasms, Plasma Cell 32Leukemia, Myeloid, Chronic-Phase 32Ovarian Neoplasms 31Leukemia, Myeloid, Accelerated Phase 30Myeloproliferative Disorders 28Dendritic Cell Sarcoma, Interdigitating 28Recurrence 27Congenital Abnormalities 27Blast Crisis 26Neutropenia 24Anemia, Refractory, with Excess of Blasts 22

Interventions

Dexamethasone 12Melphalan 7Calcium Dobesilate 6Lenalidomide 5Bortezomib 5Cyclophosphamide 4miridesap 3ixazomib 2Doxycycline 2Biopsy 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2pomalidomide 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1birtamimab 1auricularum 1Vinorelbine 1Thalidomide 1Tacrolimus 1Pharmaceutical Preparations 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Etanercept 1Drug Evaluation 1Blood Specimen Collection 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Amyloidosis × Filgrastim × Clear all
NCT01998503 2013-11-29

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Nanjing University School of Medicine

Phase 3 Completed
56 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡